Product Information
QC CHILD PAIN RLF 160 MG/5 ML is a generic product labeled by Chain Drug Marketing Association, priced at $0.0212 per ML under NDC 83324003404. Its NADAC has been published 97 times since Nov 27, 2024.
Strength
160 mg/5mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324003404
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
3/15/2024
Price Statistics
The NADAC for QC CHILD PAIN RLF 160 MG/5 ML has been published 97 times since Nov 27, 2024, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0212 per ML |
|---|---|
| All-time high | $0.0217 (Aug 12, 2026) |
| All-time low | $0.0192 (Aug 20, 2025) |
| 52-week high | $0.0217 |
| 52-week low | $0.0193 |
| Median price | $0.0208 |
| Average price | $0.0207 |
| Largest weekly change | +6.3% (Oct 22, 2025) |
| Weeks tracked | 97 |
| Tracking since | Nov 27, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC CHILD PAIN RLF 160 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for QC CHILD PAIN RLF 160 MG/5 ML, manufactured by Chain Drug Marketing Association, is $0.0212 per ML (NDC 83324003404), effective Sep 30, 2026.
How has the price of QC CHILD PAIN RLF 160 MG/5 ML changed over time?
Over the history we have for it, the NADAC for QC CHILD PAIN RLF 160 MG/5 ML has risen 3.5%. It has been tracked across 97 weekly CMS publications since Nov 27, 2024.
What are the highest and lowest recorded NADAC prices for QC CHILD PAIN RLF 160 MG/5 ML?
Since Nov 27, 2024, the NADAC for QC CHILD PAIN RLF 160 MG/5 ML has ranged from a low of $0.0192 (Aug 20, 2025) to a high of $0.0217 (Aug 12, 2026), with a median of $0.0208 per ML.
Are there cheaper alternatives to QC CHILD PAIN RLF 160 MG/5 ML?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILD PAIN-FEVER 160 MG/5 ML, is $0.0205 per ML — about 3% below QC CHILD PAIN RLF 160 MG/5 ML.
Who manufactures QC CHILD PAIN RLF 160 MG/5 ML?
QC CHILD PAIN RLF 160 MG/5 ML (NDC 83324003404) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.